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Knowledge of the subcellular distribution of proteins is vital for understanding cellular
mechanisms. Capturing the subcellular proteome in a single experiment has proven
challenging, with studies focusing on speciﬁc compartments or assigning proteins to
subcellular niches with low resolution and/or accuracy. Here we introduce hyperLOPIT, a
method that couples extensive fractionation, quantitative high-resolution accurate mass
spectrometry with multivariate data analysis. We apply hyperLOPIT to a pluripotent stem cell
population whose subcellular proteome has not been extensively studied. We provide
localization data on over 5,000 proteins with unprecedented spatial resolution to reveal the
organization of organelles, sub-organellar compartments, protein complexes, functional
networks and steady-state dynamics of proteins and unexpected subcellular locations. The
method paves the way for characterizing the impact of post-transcriptional and post-
translational modiﬁcation on protein location and studies involving proteome-level locational
changes on cellular perturbation. An interactive open-source resource is presented that
enables exploration of these data.
DOI: 10.1038/ncomms9992 OPEN
1 Department of Biochemistry, Cambridge Centre for Proteomics, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK. 2 Department of
Genetics, University of Cambridge, Downing Street, Cambridge CB2 3EH, UK. 3 Department of Biochemistry, Computational Proteomics Unit, University of
Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK. 4 Department of Pharmacology, University of Pretoria, Arcadia 0007, Republic of South Africa.
5 Thermo Fisher Scientiﬁc, 355 River Oaks Pkwy, San Jose, California 95314, USA. Correspondence and requests for materials should be addressed to K.S.L.
(email: k.s.lilley@bioc.cam.ac.uk).
NATURE COMMUNICATIONS | 7:8992 | DOI: 10.1038/ncomms9992 | www.nature.com/naturecommunications 1
P
luripotent mouse embryonic stem (ES) cells are self-
renewing clonal populations derived from blastocysts,
which can be differentiated into the ensemble of cell types
of the organism1,2. Their study is central to developmental
biology and the emerging ﬁeld of regenerative medicine.
Currently our understanding of the biology of ES cells is deeply
rooted in our knowledge of their transcriptomes, epigenetics and
underlying gene regulatory networks, which have created a
foundation for understanding pluripotency and the transition to
differentiation3,4.
There is evidence that post-transcriptional events such as
signalling, adhesion, protein turnover and post-translational
modiﬁcation make a signiﬁcant contribution to the regulation
of differentiation5–8, yet their precise roles in this process, and
how they interact with each other and with the transcriptional
machinery, remain open questions. The transition from
self-renewal to differentiation is also associated with major
changes in cell morphology, and therefore some of the effects of
these post-transcriptional processes must be associated with
changes in intracellular organization. Understanding the
subcellular distribution of proteins and other biomolecules, and
how the distribution changes with cell state, is therefore of
paramount importance for the delineation of post-transcriptional
processes in ES cells.
Protein localization is typically determined by immunocyto-
chemistry or by monitoring ﬂuorescent fusion proteins by
confocal microscopy. While these approaches are valuable and
well-established, there are certain limitations to their applicability.
Immunocytochemistry is dependent on the availability of
high-speciﬁcity and high-sensitivity antibodies, while ﬂuorescent
fusion proteins are vulnerable to aberrant localization due to the
effect of the fusion moiety on protein topology9,10. These
limitations can be overcome with complementary technologies
such as protein mass spectrometry (MS), which offers the
capability to assay thousands of proteins simultaneously and in
their native state11.
Localization of organelle proteins by isotope tagging (LOPIT)
is a quantitative proteomics method for the high throughput and
simultaneous characterization of multiple subcellular compart-
ments, without the requirement for total puriﬁcation of
compartments of interest12. LOPIT combines biochemical
fractionation by density-gradient ultracentrifugation, sample
multiplexing by in vitro covalent labelling, and liquid
chromatography-mass spectrometry. In LOPIT, cells are ﬁrst
lysed under detergent-free conditions so that there is minimal
disruption to organelle integrity. Membranes are then separated
based on their characteristic buoyant densities by
ultracentrifugation. Although organelles do not partition into
discrete puriﬁed fractions, different organelles display distinct
enrichment patterns. Fractions representing peak enrichment for
organelles of interest are selected for proteolytic digestion. The
resulting peptides are differentially labelled with amine-reactive
tandem mass tag (TMT) reagents13, which allow peptides derived
from each fraction to be distinguished by mass spectrometry. The
relative abundance of a peptide can be determined by its TMT
reporter ion proﬁle, which recapitulates the distribution of the
protein across the fractionation scheme. Proteins residing in the
same subcellular niche would be expected to co-distribute, and
therefore present similar TMT reporter ion proﬁles14.
Classiﬁcation algorithms are then used to assign proteins to
subcellular compartments based on correlation with organellar
marker proteins.
Here we signiﬁcantly extend the LOPIT concept with novel
approaches for sample preparation, mass spectrometry data
acquisition and multivariate analysis. This new workﬂow, named
hyperplexed LOPIT (hyperLOPIT), beneﬁts from several recent
technological advancements. First, the development of neutron-
encoded isotopologue variants of TMT has increased the
multiplexing capacity of isobaric tagging experiments to 10
samples15. These additional labels have enabled more subcellular
fractions to be sampled, allowing for a more elaborate
fractionation scheme that reaches sub-organellar levels of
resolution. Second, quantitative accuracy of TMT-based
applications is signiﬁcantly improved by mass spectrometry
data acquisition using synchronous precursor selection MS3 (SPS-
MS3; see Supplementary Fig. 1 for a detailed overview of this
method). Multivariate approaches such as hyperLOPIT represent
particularly demanding applications of TMT quantiﬁcation, as
consistently high accuracy and precision are necessary for co-
localized proteins to display correlated TMT distributions16. We
have therefore incorporated SPS-MS3 acquisition on the Orbitrap
Fusion Tribrid mass spectrometer (Thermo Fisher Scientiﬁc) into
the hyperLOPIT pipeline, and demonstrate that it greatly
improves spatial resolution and the reliability with which
protein localization may be determined. Finally, we have
extended our data analysis platform to facilitate rapid
interrogation of the data by providing an easy-to-use graphical
user interface.
We apply the hyperLOPIT workﬂow to a population of self-
renewing mouse ES cells. The result is comprehensive coverage of
the subcellular proteome with unprecedented spatial resolution,
enabling the mapping of components of organelles, transitory
proteins, multi-protein complexes, signalling pathways and
families of functionally related proteins. The presented data offer
hitherto unknown subcellular detail about a population of self-
renewing stem cells. We observe the dynamic nature of Golgi
apparatus proteins, noting sets of Golgi marker proteins that are
distributed amongst other subcellular structures, an observation
we support by microscopy. We also demonstrate that additional
insights into published interactomes and focused protein-
localization studies can be attained by integrative analysis with
LOPIT. HyperLOPIT offers a spatial scaffold onto which other
high content proteomics data sets can be mapped yielding added
value to complementary data. We give an example of this
functionality by combining the data presented here with a recent
data set of surface proteins captured using chemical tagging.
Results
Biochemical fractionation of mouse ES cells. An overview of the
hyperLOPIT workﬂow is shown in Fig. 1. To create a method ﬁt
for the purpose of capturing cell-wide proteome localization data,
we ﬁrst improved the LOPIT workﬂow as follows: to increase
subcellular resolution, extensive subcellular fractionation of
pluripotent E14TG2a cells was performed. First, crude
membranes were separated from the soluble fraction, enriched in
cytosolic proteins. Crude membranes were then separated into
organelle-enriched fractions by equilibrium density gradient
centrifugation, within which organelles adopt speciﬁc distribution
proﬁles consistent with their respective buoyant densities. A
portion of the cell culture was also used to enrich chromatin-
associated proteins with a parallel workﬂow based on detergent
permeabilization16. Ten fractions were chosen to best represent
peak organelle densities, labelled with TMT reagents and
processed as described in the Methods section. We acquired
three biological replicates of hyperLOPIT data, each with a
slightly different selection of subcellular fractions for TMT 10-
plex labelling. The ﬁrst replicate placed greater emphasis on
resolving low density-gradient fractions that are enriched in
secretory pathway components, while the second and third
replicates placed greater emphasis on separation of the denser
organelles such as the mitochondrion and peroxisome.
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SPS-MS3 enhances quantitative performance. TMT quantiﬁca-
tion by conventional tandem mass spectrometry (MS2) suffers
from impaired quantitative accuracy and precision due to
interference from contaminant peptides with similar chromato-
graphic and mass-to-charge properties to the target peptide.
Improved quantitative performance is achieved with an addi-
tional round of ion selection and fragmentation to purify the
analyte from which TMT quantiﬁcation is derived17,18, but such
MS3-based methods result in substantially reduced sensitivity19.
SPS-MS3 balances the quantitative gains of MS3 quantiﬁcation
with the sensitivity required for proteome-wide analysis20,21.
Whereas in conventional MS3 a single peptide fragment ion is
selected for quantiﬁcation, by using isolation waveforms with
multiple frequency ‘notches’ to collect multiple peptide
fragments, SPS-MS3 improves ion statistics for quantiﬁcation
(Supplementary Fig. 1).
To assess the impact of SPS-MS3 on quantitative performance,
we evaluated the effect of the number of SPS-MS3 ‘notches’
by comparing quantiﬁcation derived from conventional
MS2, conventional MS3 and SPS-MS3 data acquisition. Adjusting
the number of SPS-MS3 notches altered the balance
between quantitative performance and sensitivity. Increasing the
number of notches augmented the TMT reporter ion signal
intensity, and therefore the proportion of quantiﬁable spectra,
but also reintroduces contaminant ions that distort quanti-
ﬁcation. Fewer notches result in lower reporter ion signal,
with concomitant reduction in the number of quantiﬁable
spectra. We found SPS-MS3 with 10 precursors ‘notches’
to represent a suitable balance for global analysis, with
92.8% of the acquired SPS-MS3 spectra yielding TMT
reporter ion counts 41 105—a comparable ﬁgure to that
obtained with conventional MS2 acquisition (Supplementary
Table 1).
We then compared E14TG2a hyperLOPIT data sets acquired
with conventional MS2, and SPS-MS3 with 10 notches. When
comparing peptides derived from proteins with well curated
localization, we observed SPS-MS3 acquisition resulted in a
signiﬁcant improvement in quantitative accuracy over conven-
tional MS2 acquisition (Fig. 2 and Supplementary Figs 2 and 3).
This gain in quantitative performance resulted in greater
resolution of organelles from one another, and from the
median of the total peptide population; tendency towards a
uniﬁed distribution being characteristic of distorted TMT
quantiﬁcation (Supplementary Fig.18)16,22.
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Figure 1 | Schematic of the hyperLOPIT workﬂow. (a) Ten enriched subcellular fractions were generated from E14TG2a murine ES (mES) cells. Peptides
derived from each fraction were differentially labelled with TMT 10-plex reagents, and analysed by two-dimensional LC-SPS-MS3. (b) SPS-MS3 boosts the
sensitivity of MS3-based TMT quantiﬁcation, while preserving the gains in quantitative performance relative to conventional MS2, by selecting multiple
peptide fragments rather than a single ion for MS3 analysis. (c) TMT reporter ion distributions recapitulate the distribution of proteins across the
fractionation scheme. Different organelles display characteristic distributions that may be used to determine their residents. The high dimensional data are
presented in two-dimensions by PCA to provide an intuitive visualization of organelle separation.
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While the increase in instrument duty cycle to perform
SPS-MS3 decreased the number of quantiﬁed peptide-spectrum
matches (PSMs) from 137,912 to 61,090, the difference between
the number of quantiﬁable protein groups was less substantial
(7,114 versus 5,489)—a tolerable compromise given the gains in
spatial resolution (Supplementary Fig.17).
HyperLOPIT provides an overview of protein localization.
Over 6,000 protein groups were quantiﬁed in each of the three
replicate experiments (Supplementary Data 1). The
fractionation patterns observed in experiments 1 and 2 are highly
consistent, while the resolution of secretory pathway organelles in
experiment 3 was reduced owing to lower protein yields
(Supplementary Fig. 4). Despite the lower resolution of some
compartments in experiment 3, classiﬁcation of proteins to
subcellular compartments was highly reproducible, with o5% of
proteins assigned contradictory localizations across the three
experiments (Supplementary Fig. 5).
The intersect of experiments 1 and 2 (5,032 protein groups,
Supplementary Data 1) was treated as a 20-plex data set for the
analysis discussed in this article, which has previously been
demonstrated to improve the attainable spatial resolution23,24.
Experiment 3 was not included, as little additional resolution was
obtained by further data fusion.
Using the pRoloc data analysis pipeline25, an initial application
of novelty detection26 was conducted to identify and conﬁrm the
presence of organelle clusters in an unbiased data-speciﬁc
manner, followed by supervised classiﬁcation using a support
vector machine (SVM) for ﬁnal protein-organelle assignment.
Applying SVM scoring thresholds based on concordance with
gene ontology annotation, the steady-state localization of 2,855
out of a total of 5,032 protein groups were unambiguously
determined (Fig. 3 and Supplementary Figs 6 and 7). Sub-nuclear
resolution was also obtained, with proteins localized to
chromatin, non-chromatin nuclear and nuclear lamina
displaying distinct quantitative distributions. Manual curation
of the data set also revealed co-localization of proteins for several
other subcellular niches, including coatamer and clathrin-coated
vesicles, and cytoskeletal fragments (Fig. 3).
Given the breadth of proteome coverage and subcellular
resolution, hyperLOPIT can be used to investigate the organiza-
tion of cells at multiple levels of scope. Insights into cell behaviour
may be drawn from the localization of individual proteins,
protein families and even functional networks, or by evaluating
the protein content of particular subcellular compartments. In the
following sections, we discuss how some of the layers of data can
be interpreted, and the insights into the organization of
pluripotent ES cells that may be drawn.
Organelle membership. The hyperLOPIT workﬂow enabled
unambiguous assignment of 2,855 proteins to 14 discrete
organellar and sub-organellar compartments in a single
experiment. This number amounted to over 50% of the proteins
identiﬁed, with the remainder displaying intermediate
distributions as described in the Proteins in transit section. The
classiﬁed proteins represent both residents of an organelle, as
well as transient trafﬁckers or cargo proteins that are captured in
this position under these experimental conditions and in this
particular cell type. The catalogue of organelle members is
therefore context speciﬁc and must be viewed as a subcellular
snapshot of a dynamic system.
Approximately 83% of proteins classiﬁed by hyperLOPIT
carry localization-speciﬁc gene ontology annotation, with
only 39% of these proteins annotated based on direct assay
evidence. This data set therefore provides new experimental
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Figure 2 | SPS-MS3 enhances resolution of the mitochondrion from other
organelles. (a) SPS-MS3 results in higher quantitative accuracy. The ratio
between TMTchannels expected to be enriched in mitochondria (129C and
130N) and channels that are expected to be depleted (for example, 130C) is
markedly increased by SPS-MS3. (b) The distance of mitochondrial PSMs
from the median of eight organellar phenotypes. The distance of
mitochondrial PSMs from the median mitochondrial distribution does not
change signiﬁcantly between MS2 and SPS-MS3, but the distances from
other organelles are all signiﬁcantly increased in SPS-MS3 (Wilcoxon rank
sum test P value o2.2 10 16), indicating greater organellar resolution.
(c) When represented in two dimensions by PCA, the mitochondrial PSMs
(red heat map) show less skew towards the origin, due to the improved
speciﬁcity of SPS-MS3 quantiﬁcation. The median positions of other
organelles are represented by coloured squares and individual proteins by
grey points. Similar plots demonstrating the enhanced resolution of other
organelles are presented in Supplementary Fig. 2.
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evidence for the localization of 1,775 murine proteins, B350 of
which currently lack organelle-speciﬁc localization information
in the UniProt database (Supplementary Data 1). It should
be noted that these values include proteins that are annotated
as cytoplasmic. Since the term cytoplasm incorporates
the cytosol, cytoskeleton, organelles and other cellular features
other than the nucleus and cell surface, such annotation
lacks the speciﬁcity to be suitably informative in this context.
HyperLOPIT is therefore a useful tool for supplementing
database annotation of protein localization with high
throughput. Another key strength of the approach is that
protein localization may be determined in particular cell type(s)
and cell state(s) of interest—information that is typically lacking
in gene ontology annotation or computational prediction of
localization.
We compared the protein localizations determined by
hyperLOPIT with another recently published plasma membrane
proteome for the same cell line. Bausch-Fluck et al.27 identiﬁed
plasma membrane proteins by cell surface biotinylation and
afﬁnity puriﬁcation-mass spectrometry. In this study the
authors categorized their cell capture data into three groups:
High conﬁdence, for proteins with UniProt keywords including
‘Cell junction’, ‘Cell membrane’ and ‘Secreted’; putative, for
proteins with predicted transmembrane domains, but none of
the above keywords assigned; and non-speciﬁc, for other
identiﬁed proteins, which were assumed to be abundant
contaminant proteins. Proteins labelled as high conﬁdence in
this study corroborate with their localization in the hyperLOPIT
data, as almost all such proteins localize to the plasma
membrane or endosomes—suggesting extensive recycling of
some of these surface proteins. HyperLOPIT also conﬁrms
plasma membrane localization for many proteins labelled as
putative in the Bausch-Fluck study (Supplementary Fig. 8). The
third category, non-speciﬁc proteins, consists mostly of proteins
found in non-surface localizations by hyperLOPIT. The strong
correlation of results demonstrates that hyperLOPIT may also
be used as an orthogonal validation method for targeted
localization studies.
Proteins in transit. Not all proteins are expected to partition into
discrete subcellular compartments. While over half of the
quantiﬁed proteins were classiﬁable to a single and unambiguous
location, many proteins were found to have distributions that did
not closely correlate with those of the 14 classiﬁed subcellular
compartments. These less discrete distribution patterns occur for
several reasons.
First, proteins present in multiple compartments will adopt
quantitative distributions that reﬂect their steady-state subcellular
enrichment. b-catenin for example, has been robustly classiﬁed to
the plasma membrane despite the fact that this protein is known
to localize to the adherens junctions, cytosol and nucleus.
Classiﬁcation to the plasma membrane reﬂects its relative
enrichment at the adherens junction in ES cells cultured
under self-renewing conditions, which has been previously
demonstrated by immunoﬂuorescence microscopy28.
There are cases where the steady-state localization is not so
skewed towards one of multiple compartments. For example,
many components of the nuclear import and export machinery
display distributions consistent with mixed localization between
the cytosol and nucleus (Supplementary Fig. 9). These proteins
were not classiﬁed as unambiguous residents of either the nucleus
or cytosol; their distribution patterns accurately reﬂect their true
subcellular localization. Other proteins displaying mixed localiza-
tions include signalling cascade effectors, such as Erk-2 and the
adaptor protein Grb-2, components of the MAP kinase signalling
pathway that distribute between the plasma membrane and
cytosol, reﬂecting the dynamic transitions between the two
locations. For some proteins with mixed localization the
distribution patterns are quite complex. Mcl-1, a Bcl-2 family
member protein, displays a three-way mixed localization between
the endoplasmic reticulum, mitochondrion and nucleus, and
therefore falls between the three organelle clusters in principal
component analysis (PCA) space; this broad distribution is
consistent with previous confocal microscopy analysis of its
human orthologue29.
The steady-state distribution of transitory proteins can provide
information about the state of the cell population. For example,
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Tfe3, a helix–loop–helix family transcription factor and
modulator of the exit of ES cells from pluripotency, was observed
with mixed localization between the cytoplasm and nucleus
(Supplementary Fig. 9), consistent with immunocytochemistry
data in ES cells. In the pluripotent state, Tfe3 localizes to both the
nucleus and cytosol, and regulates the expression of key
pluripotency factor Esrrb. In the early stages of differentiation,
it is excluded from the nucleus30.
Second, intermediate subcellular distributions may represent
proteins residing in organelles other than those used in the SVM
classiﬁcation. These compartments typically have their own
physicochemical properties, and their resident proteins therefore
co-localize, but are not sufﬁciently enriched for their distribution
patterns to be fully resolved from those of other subcellular
compartments. For example, known components of the clathrin-
AP3 trafﬁcking vesicles were found to co-localize away from
other organelles and vesicles, but were not distinct from other
proteins with mixed localization. Some proteins with correlated
distributions to the clathrin-AP3 vesicles are plausible vesicular
components, such as syntaxin-18, whereas others are transitory
cytosolic and cytoskeletal proteins such as serine/threonine kinase
Pak4.
Finally, the observed localization patterns may represent
proteins that comprise or are tethered to the cytoskeleton. The
fractionation pattern of the cytoskeleton is not easily predicted
given its broad interconnectivity with other subcellular compo-
nents. We observed groups of cytoskeletal proteins with a variety
of distinct distributions, including actin, actin-capping modula-
tors, microtubules, microtubule organizing centre components,
dyneins, kinesins and myosins (Supplementary Fig. 10). While we
did not perform classiﬁcation on these smaller phenotypes, it is
possible that uncharacterized proteins that co-localize with these
niches are cytoskeletal components.
Organelle structure. The ability of hyperLOPIT to gain insight
into very dynamic processes within the cell is exempliﬁed by the
Golgi apparatus. The position of well documented Golgi appa-
ratus marker proteins reveals an unexpected observation about
these cells. As can be seen from Fig. 4a, these markers fall into
four categories; proteins that co-cluster with endoplasmic
reticulum (ER) markers, proteins that lie between the ER/Golgi
and endosomal compartments, proteins that cluster with plasma
membrane markers, and proteins whose steady-state location
does not correlate with any of the 14 classiﬁed compartments.
The proteins that cluster along with ER markers are generally
annotated as being cis-Golgi proteins, including alpha-mannosi-
dase 2 (MA2A1)31 and members of the SNAP receptor complex
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(GOSR2)32. Proteins that cluster towards the endosomal markers
are associated with the trans-Golgi, such as the
copper-transporting ATPase (ATP7A)33 and vacuolar protein
sorting-associated protein 45 (VSP45)34. Several proteins form
part of the plasma membrane cluster including Ras-related
protein Rab-6A (RAB6A)35 and Golgin 7 (GOGA7), which are
thought to be involved in protein transport from the Golgi to the
cell surface36. In general those proteins known to be peripherally
associated with Golgi membranes lie in an intermediate position
on the boundary of the ER/Golgi cluster, for example, the
Golgi phosphoprotein GOLP3 and oxysterol-binding protein 1.
It is curious to note that some Golgi marker proteins occupy a
steady-state position far removed from the ER/Golgi or
endosomal vesicles. GM130 (GolginA2) is a cis-Golgi
matrix protein, and is thought to be involved in regulation of
centrosomes during interphase37. On the PCA plot (Fig. 4A),
GM130 is intriguingly at a steady-state position between
centriolar proteins such as pericentriolar material 1 protein
(PCM1), centrin 2 (CETN2), spindle and centriole-associated
protein (SPICE), pericentrin (PCNT) and another cluster of
proteins containing gamma tubulin subunits and centrin 3
(CETN3)38–40. This is consistent with the role of GM130 to act as
a tether between the Golgi and centrosomes in interphase41. To
conﬁrm our observations, we performed immunocytochemistry
imaging with an anti-GM130 antibody, which supported the
theory that this protein may be associated with the centriole in
pluripotent mouse ES cells (mES; Fig. 4b). Interestingly, we noted
that GM130 instead appeared to be associated with Golgi-like
structures when the cells are transferred to a media promoting
neural differentiation (N2B27 medium; Fig. 4c,d). The reasons
behind the difference in distribution of GM130 observed between
self-renewing and differentiating ES cells may reﬂect the relative
dwell times of the two sets of cells in the stages of the cell cycle42,
and it has previously been reported that mES cells have a
truncated G1 phase43. The distribution of GM130 and is
proximity to centriolar and pericentriolar matrix proteins may
reﬂect that the majority of pluripotent cells are in the later stages
of the cell cycle. Although the data do not show direct tethering of
Golgi and centrosomal complex structures, this is just one
example of how these data provide a snapshot of cellular
behaviour.
Protein complexes. In addition to organelles, we observed that
many protein complexes display highly correlated distribution
patterns. Co-localization of highly abundant macromolecular
protein complexes, such as ribosomal subunits and the
mitochondrial ATP synthase complex by LOPIT has been
previously demonstrated44. The depth of proteome coverage in
this study, coupled with the high subcellular resolution derived
from precise quantiﬁcation, enabled many more complexes to be
detected. We selected 30 examples of highly curated protein
complexes listed in KEGG45 and Reactome46,47, and annotated
their distributions in the hyperLOPIT data (Fig. 5). There are
many other protein complexes represented in the data set that we
have not curated, but which readers of this study can explore
according to their particular interest using pRolocGUI.
Proteins with multiple functional roles within the cell may be
involved in more than one protein complex. Neither the extent of
this, nor the distribution of components between these complexes
is typically captured in large-scale complex puriﬁcation studies.
Inspection of the steady-state position of complex components
within hyperLOPIT data indicates that components have
differing positions from the core complex members, and may
even indicate those that function in a regulatory manner. For
example, the steady-state location of the TFIID complex is
nuclear in these data, however, Taf7 has a steady-state
distribution that is distinct from the other complex components
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Figure 5 | Examples of soluble and organellar protein complexes. Protein complexes are distributed throughout principal component space. Some soluble
protein complexes display characteristic distributions that may reﬂect mixed localization, partitioning of the cytoskeleton by the fractionation scheme, or
the unique sedimentation properties of these macromolecular structures. Sub-organellar distribution of complexes were observed in both ER,
mitochondrion and nucleus.
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(Supplementary Fig. 9). This may reﬂect the fact that Taf7 is
thought to dissociate from the pre-initiation TFIID complex
following initiation of transcription48. Another example is the
exocyst complex, where Exoc8 is localized away from the core
exocyst complex in these data, and co-distributes with its known
binding partners Par6 and RalA49.
To demonstrate the utility of these data in evaluating other
high-throughput data sets, we annotated the murine orthologues
of proteins that were characterized in a census of human soluble
protein complexes50. By adding this subcellular context to the
analysis, we see that well-established components of protein
complexes tend to co-localize, whereas novel assignments and
putative uncharacterized complexes display more varied
localization (Supplementary Fig. 11). Novel assignments that
co-localize with the ‘core’ complex might be assumed to be stable
interactors, whereas those with different subcellular distributions
may be transient interactors or false assignments. For example,
two of eight novel components of the 39S mitochondrial
ribosomal subunits assigned by Havugimana et al.50 were found
to co-localize to the mitochondrion, whereas the remaining six
were distributed in the nucleus, cytosol and secretory pathway
(Supplementary Fig. 11C). The two co-localized proteins
(Ict1 and Mrp63) both feature mitochondrial signal peptides
and have molecular functions consistent with translation. The
mouse and human variants of the six other putative interactors do
not contain a distinct signal peptide, and are therefore probable
false assignments in the census data set.
Functional networks. The high proteome coverage generated by
hyperLOPIT enabled us to determine the localization of many
proteins associated with pluripotency and differentiation,
including components of the core transcriptional network of
pluripotent cells such as Sox2, Oct4 and Nanog. Also, impress-
ively, the subcellular distributions of the components of
FGF/MAPK, canonical Wnt, Notch, BMP/SMAD, Nodal, Ras and
Hippo signalling pathways are apparent, paving the way for
using hyperLOPIT to determine modulation in the location of
signalling proteins and their effectors on activation/deactivation
of multiple signalling pathways during, for example, differentia-
tion (Supplementary Fig. 12). During self-renewal, Wnt/b-catenin
and FGF/MAPK signalling are maintained at a low level28.
Consistent with this, we observe that b-catenin is ﬁrmly located
in the plasma membrane and that Sprouty proteins, negative
regulators of FGF/ERK signalling, are also associated with the
membrane, where they act to inhibit the early stages of FGF
signalling. We also observe extranuclear localization of Smad2/5,
consistent with the known low Nodal/Activin signalling in
self-renewal42. To our knowledge this is the ﬁrst instance in
which it is possible to have a snapshot of all signalling pathways
in one cell.
To evaluate the spatial distribution of interaction partners for
the core pluripotency transcription factor triad of Oct4, Sox2 and
Nanog, we overlaid information from three high-throughput
protein–protein interaction studies onto the E14TG2a hyperLO-
PIT data set51–53. As might be expected, the seven interaction
partners that were common to all three bait proteins displayed
steady-state enrichment to chromatin (Supplementary Fig. 13D).
Three of these common interaction partners (Chd4, Mta1 and
Mta2) are components of the NuRD complex, demonstrating the
importance of chromatin remodelling for maintenance and exit
from the pluripotent state54. While the interactome was found to
be chromatin centric, each of the transcription factors was
also reported to interact with proteins that we observed with
subcellular enrichment away from chromatin by hyperLOPIT
(Supplementary Fig. 13A–C). The functional implications of these
non-chromatin interactors are of potential interest, as their
differential localization suggests that trafﬁcking of the interaction
partners into the nucleus, or of the transcription factor to
extranuclear locations, plays a role in modulating the interaction.
Alternatively, protein–protein interactions that are far removed
may be indicative of a false discovery, as described previously for
the 39S ribosomal subunit.
Protein isoforms. HyperLOPIT can also provide information
on the localization of protein isoforms. The impact of post-
transcriptional modiﬁcation on protein location has been
previously documented55, however observation of the differences
in subcellular location of closely related isoforms has not been
previously possible using LOPIT, as the accuracy of quantiﬁcation
was insufﬁcient to reliably characterize the few peptides, or often
single peptide, which distinguish protein isoforms. With the
enhanced quantitative performance of TMT quantiﬁcation by
SPS-MS3, measurements based on few peptides still yield reliable
reporter ion distributions that allow us to characterize
localization. We observed unique evidence for 25 and 26 pairs
of protein isoforms (distinct proteins sharing the same gene name)
in experiments 1 and 2, respectively (Supplementary Data 1).
Some of the detected protein isoforms were found to
co-localize, while others were found to be differentially localized.
For example, two murine isoforms of Leucine aminopeptidase 3
(Lap3) have been reported to arise from alternative translational
initiation codons in the same mRNA; a ‘long’ canonical isoform,
and a ‘short’ isoform with a 31 residue N-terminal truncation.
We observed the ‘long’ isoform of Lap3 with unambiguous
mitochondrial localization, whereas the ‘short’ isoform was found
with a steady-state distribution between the cytosol and plasma
membrane (Supplementary Fig. 14A). Protein-localization
algorithms based on primary sequence, such as WoLF PSORT
(ref. 56), support the observation that the long isoform of Lap3
localizes to mitochondria, whereas the short isoform does not
(although the speciﬁc localization of the short isoform within the
cytoplasm is not predictable from sequence alone). This suggests
that the two isoforms, while sharing a common catalytic activity,
fulﬁl separate biological roles due to differential localization. The
differential localization is achieved through alternative translation
that incorporates or excludes an N-terminal mitochondrial target
signal. Further credence is given to the dual localization
determined by hyperLOPIT by the fact that predicted
functional partners of Lap3 (Anpep, Cat, Ggt1, Gss, Hspd1 and
Pycr), as reported by the STRING protein interaction database
(v9.1 (ref. 57)), are found to localize to the mitochondrion,
plasma membrane, and cytosol—the three subcellular compart-
ments described by the steady-state localization of the two Lap3
isoforms.
The differential localization of some other isoforms is not as
straightforward to interpret. Two isoforms of Dnmt1, a DNA
(cytosine-5)-methyltransferase that modulates ES cell pluripo-
tency by maintaining CpG methylation patterns58 were identiﬁed;
a canonical ‘long’ isoform, and ‘short’ isoform with an 118 residue
N-terminal truncation that removes the Dmap interacting
domain. The canonical isoform distribution was consistent with
localization to chromatin, and closely co-localizes with Dmap1.
The short isoform also appears to localize to the nucleus, but with
an atypical distribution proﬁle that while most similar to
chromatin, is distinct from the typical chromatin proﬁle
(Supplementary Fig. 14B). The signiﬁcance of this differential
nuclear distribution is not immediately clear59.
While the number of isoforms pairs identiﬁed here is relatively
modest, the depth of attainable proteome coverage will increase as
the speed and sensitivity of high-resolution accurate mass
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spectrometry continues to advance, and will allow more of these
isoforms to be detected. Accurate quantiﬁcation of proteins based
on a single peptide measurement will also permit characterization
of post-translationally modiﬁed peptides. The ability to function-
ally characterize post-translational variants of proteins is an
exciting avenue of research, as such variants introduce an
additional dimension of biochemical complexity that is not easily
evaluated with high throughput.
Discussion
The hyperLOPIT technique is a systematic and accurate assay for
characterizing the localization of thousands of proteins in a single
experiment, and is applicable to many biological model systems.
Application of this technology to a self-renewing population of ES
cells has generated the most extensive analysis of protein
localization in a stem cell line to date. The data contain
information about organelle residency of proteins, sub-organellar
structure, the impact of isoform status on location and dynamic
localization of proteins. This creates a reference for mapping
proteins relative to each other in pluripotency and differentiation.
HyperLOPIT data may also be used to provide a spatial context
for pre-established protein complexes and functional networks.
For example, our results provide molecular support for some
functional observations about the state of several signalling
pathways in ES cells. HyperLOPIT can also be used as an
orthogonal approach for validation of targeted localization
studies, as we have demonstrated with the cell surface proteome
generated by Bausch-Fluck et al.27
The E14TG2a data set we present acts both as a resource for
interrogating the subcellular location of proteins of interest to
researchers, and also acts as a scaffold onto which other high
content data sets may be mapped to assist in their interpretation.
HyperLOPIT is a powerful tool for gaining insights into
fundamental post-translational processes governing stem cell
behaviour.
Methods
Cell culture. Murine pluripotent ES cells (cell line E14TG2a) a kind gift from
Professor Austin Smith, University of Cambridge, and available from American
Type Culture Collection (CRL-1821), were maintained in culture on gelatinized
ﬂasks in a media containing fetal bovine serum supplemented with leukaemia
inhibitory factor (LIF), as previously described60. Approximately 108 cells were
collected by trypsinization and washed several times with phosphate buffered
saline. Cell suspension (10%) was aliquoted for chromatin extraction, while the
remaining 90% was used for membrane fractionation.
Immunocytochemistry. E14TG2A mES cells were plated and stained as described
in ref. 42 using anti-GM130 (AbCam—EP829Y) and KDel (AbCam—ab50601),
and imaged by confocal microscopy.
Cell lysis and subcellular fractionation. For density-gradient ultracentrifugation,
cell pellets were resuspended in 15ml lysis buffer (0.25M sucrose, 10mM HEPES
pH 7.4, 2mM EDTA, 2mM magnesium acetate) containing protease inhibitors
(Roche), and lysed with a ball-bearing homogenizer (Isobiotec) on ice. Lysate
viscosity was reduced by treatment with 25Uml 1 benzonase endonuclease
(Invitrogen) for 20min at room temperature. Insoluble cellular debris was removed
by centrifugation at 200g, 5min at 4 C. The supernatant was retained and the
centrifugation step was repeated a further two times.
Optiprep density-gradient medium (60% w/v iodixanol, Sigma) was diluted to a
working solution of 50% w/v iodixanol with 6 lysis buffer (60mM HEPES pH
7.4, 12mM EDTA pH 8.0, 12mM magnesium acetate), containing protease
inhibitors. Solutions with varying concentrations of iodixanol were then made by
mixing the iodixanol working solution and lysis buffer. The iodixanol
concentration of each solution was veriﬁed by measuring refractive index using a
handheld refractometer (Reichert Technologies).
The lysate was divided between several 5ml polyallomer ultracentrifuge tubes
(Beckman), and underlaid with 0.8ml of 6% w/v iodixanol solution, and then
with 0.8ml of 25% w/v iodixanol solution. Samples were centrifuged in an Optima
XL-80 ultracentrifuge (Beckman), SW55Ti rotor at 100,000g, 60min at 4 C. The
resulting supernatant was retained as a ‘soluble fraction’ (enriched in cytosolic
proteins), and crude membranes were collected from the interface of the two
iodixanol layers. The crude membrane fraction was diluted with lysis buffer and
pelleted by ultracentrifugation in the SW55Ti rotor at 200,000g, 40min at 4 C to
remove any residual cytosol from the membranes. The washed membrane pellet
was then resuspended in 25% w/v iodixanol solution, and underlaid beneath a
pre-formed gradient composed of 8, 12, 16 and 20% iodixanol layers, which was
left for 8 h at 4 C to diffuse to linearity. The continuous density gradient was
centrifuged at 100,000g for 8 h in a VTi65.1 rotor at 4 C with slow braking to
minimize gradient disruption. Following ultracentrifugation, 20 0.5ml gradient
fractions were collected using an Auto Densi-Flow peristaltic pump with meniscus
tracking probe (Labconco). The refractive indices of all fractions were measured to
determine the shape of the ﬁnal gradient. Each fraction was then diluted with
0.8ml lysis buffer, and centrifuged in a TLA-55 ﬁxed angle rotor at 180,000g in an
Optima MAX-XP benchtop ultracentrifuge (Beckman), 20min at 4 C. This
centrifugation step was repeated for all fractions, the supernatant was discarded
and the resulting membrane-enriched pellets were stored at  20 C. Four volumes
of chilled acetone were added to the cytosolic fraction and the chromatin-enriched
fraction, and protein precipitation was carried out overnight at  20 C. The
acetone samples were centrifuged and air-dried before solubilization in 8M urea,
0.1% SDS, 25mM tetraethylammonium bromide (TEAB; pH 8.5). The density-
gradient membrane-enriched pellets were also resuspended in 8M urea buffer.
Samples were brieﬂy sonicated on ice to ensure re-solubilization.
The reproducibility of gradients from three independent biological replicates
can be found in Supplementary Table 2.
Chromatin extraction and enrichment. Chromatin extracts were prepared as
previously described61. Brieﬂy, cells were resuspended in chromatin buffer
A (10mM HEPES pH 7.9, 10mM KCL, 1.5mM MgCl2, 0.34M sucrose, 10%
glycerol, 1mM dithiothreitol) with protease inhibitors. Triton X-100 was added
to a concentration of 0.1% v/v and incubated on ice for 8min to lyse the cells.
Nuclei were pelleted by centrifugation at 1,300g, 5min at 4 C. The nuclear pellet
was resuspended in chromatin buffer B (3mM EDTA, 0.2mM EGTA, 1mM
dithiothreitol) with protease inhibitors and incubated for 30min on ice. Samples
were then centrifuged at 1,700g, 5min at 4 C. The chromatin-enriched pellet was
washed in chromatin buffer B, re-pelleted and stored at  20 C.
Protein digestion and TMT 10-plex labelling. Protein concentrations were
determined by BCA assay (Thermo Fisher Scientiﬁc) as per the manufacturer’s
instructions. Optimal fractions were selected for TMT 10-plex labelling based on
western blot evaluation of organelle marker proteins, protein concentration and
refractive indices of membrane fractions. Protein (50mg) from 10 differentially
enriched subcellular fractions (8 membrane fractions from the density gradient,
plus cytosol and chromatin-enriched fractions, Supplementary Table 3) was
reduced, alkylated and digested with trypsin. Brieﬂy, each sample was made up
to a total volume of 50 ml with 25mM TEAB and reduced and alkylated. Disulﬁde
bonds were reduced with 5 ml of 200mM tris(2-carboxyethyl)phosphine,
1 h at 37 C, followed by alkylation of cysteine residues with 5 ml of 375mM
iodoacetamide, 30min at room temperature. Samples were then diluted tenfold
with 25mM TEAB and digested with sequencing grade trypsin (Promega) for
1 h with a 1:40 enzyme:protein ratio, 37 C. An additional aliquot of trypsin at
1:40 concentration was added and incubated overnight at 37 C. Trypsin digests
were centrifuged for 10min at 13,000g to remove any insoluble matter, then
reduced to dryness by vacuum centrifugation.
While the TMT tags were equilibrating to room temperature, peptide samples
were resuspended in 30ml 1M TEAB and 70ml isopropanol. The solubilized
samples were transferred into the tag vials and placed on a shaker for 2 h at room
temperature. The reaction was quenched by addition of 8 ml 5% hydroxylamine for
30min. The labelled samples were then combined and reduced to dryness by
vacuum centrifugation. C18 solid-phase extraction was performed using Sep-Pak
cartridges (100mg bed volume, Waters) and peptides were eluted in 70%
acetonitrileþ 0.05% acetic acid. The eluate was again reduced to dryness by
vacuum centrifugation, and resuspended in 20mM ammonium formate (pH 10.0),
for high pH reversed-phase liquid chromatography.
Sample fractionation. Desalted peptides were resuspended in 0.1ml 20mM
ammonium formate (pH 10.0)þ 4% (v/v) acetonitrile. Peptides were loaded onto
an Acquity bridged ethyl hybrid C18 UPLC column (Waters; 2.1mm inner
diameter 150mm, 1.7 mm particle size), and proﬁled with a linear gradient of
5–60% acetonitrileþ 20mM ammonium formate (pH 10.0) over 60min, at a ﬂow
rate of 0.25mlmin 1. Chromatographic performance was monitored by sampling
eluate with a diode array detector (Acquity UPLC, Waters) scanning between
wavelengths of 200 and 400 nm. Fractions were collected at 1min intervals.
Twenty-four fractions representing peak peptide elution were selected for mass
spectrometry analysis and resuspended in 0.05% triﬂuoroacetic acid.
Approximately 1 mg peptides were loaded per liquid chromatography-mass
spectrometry run.
Mass spectrometry. All mass spectrometry experiments were performed on an
Orbitrap Fusion coupled with a Proxeon EASY-nLC 1000 (Thermo Fisher
Scientiﬁc). Peptides were separated on a Proxeon EASY-Spray column (Thermo
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9992 ARTICLE
NATURE COMMUNICATIONS | 7:8992 | DOI: 10.1038/ncomms9992 | www.nature.com/naturecommunications 9
Scientiﬁc; 50 cm 75mm inner diameter, 2 mm particle size and 100Å pore size).
Separation was achieved by applying a 5–25% gradient of acetonitrileþ 0.1%
formic acid over 95min at 300 nlmin 1, followed by 25–40% acetonitrileþ 0.1%
formic acid over 10min. An electrospray voltage of 1.8 kV was applied to the eluent
via the EASY-Spray column electrode.
The Orbitrap Fusion was operated in positive ion data-dependent mode for
both MS2 and SPS-MS3 methods. For the MS2 method, the full scan was performed
in the Orbitrap in the range of 300–1,600 m/z at nominal resolution of 1.2 105,
followed by selection of the most intense ions above an intensity threshold of
2 104 for high-energy collisional dissociation (HCD)-MS2 fragmentation. Ion
ﬁltering for MS2 events was performed by the quadrupole with a transmission
window of 1.5 m/z. HCD fragmentation was performed with 40% normalized
collision energy, followed by analysis of fragment ions in the Orbitrap with
nominal resolution of 6 104. The number of HCD-MS2 events between full scans
was determined on-the-ﬂy so that the duty cycle was ﬁxed at 3 s.
The automatic gain control (AGC) settings were 4 105 ions and 1 105 ions,
and maximum ion accumulation times to 50 and 120ms, for full and MS2 scans,
respectively. Ions with 1þ or undetermined charge state were excluded from MS2
selection. Ions within a±10 p.p.m. m/z window around ions selected for MS2 were
excluded from further selection for fragmentation for 35 s.
For the SPS-MS3 method, the full scan parameters were identical to those for
the MS2 method. The most intense ions above a threshold of 2 104 were selected
for collision induced dissociation (CID)-MS2 fragmentation, with an AGC target
and maximum accumulation time of 1 104 and 70ms. Mass ﬁltering was
performed by the quadrupole with 1.5 m/z transmission window, followed by CID
fragmentation in the linear ion trap with 35% normalized collision energy. SPS was
applied to co-select 10 fragment ions for HCD-MS3 analysis. SPS ions were all
selected within the 400–1,000 m/z range, and were set to preclude selection of the
precursor ion and TMTC ion series62. AGC targets and maximum accumulation
times were set to 1 105 and 120ms. Co-selected precursors for SPS-MS3
underwent HCD fragmentation with 55% normalized collision energy, and were
analysed in the Orbitrap with nominal resolution of 6 104. The number of SPS-
MS3 spectra acquired between full scans was restricted to a duty cycle of 3 s.
To assess the effect of using different numbers of precursors for SPS, ions were
selected from full scans as described above. For each selected peptide ion, a
sequence of six spectra was generated (conventional MS2, SPS with 15, 10, 5 and 2
precursors, and conventional MS3). The precursor ion for conventional MS3 was
selected as the most intense ion within the 400–950 m/z range, excluding the
unfragmented peptide and TMTC ion series, and isolated with a 2 m/z selection
window. Conventional MS2 and SPS-MS3 were performed with the parameters
described previously. The duty cycle for the sequence of scans was ﬁxed at 6 s, with
each sequence of six scans taking B1.5–2.5 s.
Data processing. Raw data ﬁles were processed using Proteome Discoverer
(v1.4, Thermo Fisher Scientiﬁc), interfaced with Mascot server (v2.3.02, Matrix
Science). Mascot searches were performed against SwissProt mouse database
(March 2013, 24,481 sequences), with carbamidomethylation of cysteine, and TMT
10-plex modiﬁcation of lysine and peptide N termini set as modiﬁcations. For the
MS2 method, in which identiﬁcation was performed at high resolution in the
Orbitrap, precursor and fragment ion tolerances of±20 p.p.m. and±0.2Da were
applied. For the SPS-MS3 method, in which identiﬁcation was performed at lower
resolution in the linear ion trap, tolerances of ±20 p.p.m. and ±0.5Da were
applied. Up to two missed tryptic cleavages were permitted. Searches were also
performed against a sequence scrambled ‘decoy’ database. The PSMs for the
‘forward’ and ‘decoy’ searches by Mascot were re-scored using the Percolator
algorithm to yield a more robust false discovery rate63.
TMT 10-plex quantiﬁcation was also performed by Proteome Discoverer by
calculating the sum of centroided ions within ±2mmu window around the
expected m/z for each of the 10 TMT reporter ions. For SPS-MS3 methods,
quantiﬁcation was performed at the MS3 level. Spectra with more than four missing
reporter ion values were excluded from quantiﬁcation, and remaining missing
values were set as zero for downstream analysis. For protein-level reporting,
protein grouping was enabled, and values were calculated from the median of all
quantiﬁable PSMs for each group. TMT values were then reported as a ratio to the
sum of reporters in each spectrum (that is, the sum of the 10 values for each
spectrum was equal to 1).
To evaluate the effect of the number of SPS notches on quantitative
performance, data were ﬁrst processed as described above. SPS data were then
extracted from scan headers in the raw data ﬁles by a VB.NET script using
MSFileReader libraries (Thermo Fisher Scientiﬁc). SPS data and reporter ion
quantiﬁcation were then paired with the peptide identiﬁcation information
reported by Proteome Discoverer.
Machine learning and multivariate data analysis. The Bioconductor64 packages
MSnbase65 and pRoloc25 for the R statistical programming language66 were used
for handling of the quantitative proteomics data and the protein-localization
prediction. We employed the use of the full pRoloc pipeline in which proteins are
assigned to a subcellular localization using a multi-step analysis framework.
Using the pRoloc software25, an initial application of novelty detection26 was
conducted to identify and conﬁrm the presence of organelle clusters in an unbiased
data-speciﬁc manner. The novelty detection analysis was run as described in
Breckels et al.26 using the classic Gaussian ellipsoidal mixture models for
multivariate data, a stringent 200 iteration run (N¼ 200), and outlier detection
testing at the 5% level (P¼ 0.05). The minimum number of proteins per new
phenotype cluster was set to 20 proteins (GS¼ 20), to allow detection of small
organelles and complexes. A set of well-known residents from three distinct
organelle structure; the mitochondria, plasma membrane and ER, and from three
well-known and abundant protein complexes; the proteasome and two ribosomal
subunits, 40S and 60S, were used as initial input markers for the discovery analysis
(Supplementary Table 4). These initial markers were manually curated using
information from the UniProt database67, the Gene Ontology68 and the literature.
From the nature of the experimental design it was known that nuclear structures
existed within the data, however, nuclear markers were left unlabelled in the
discovery analysis to allow an unbiased detection of any sub-nuclear clusters. Also,
markers that cover the lysosome, peroxisome and endosome were also left
unlabelled to obtain an unbiased data-speciﬁc conﬁrmation of their presence.
Supplementary Fig. 15 shows the results of the discovery analysis and
Supplementary Tables 5 and 6 show the number of clusters identiﬁed and the ﬁnal
marker set to be used in protein classiﬁcation. This ﬁnal set contained 13 different
subcellular structures; the mitochondria, ER, plasma membrane, lysosome,
peroxisome, endosome, actin cytoskeleton, extracellular matrix, nucleus
(non-chromatin), chromatin, proteasome, 40S and 60S ribosomal subunits and the
cytosol which were deﬁned through a careful manual search of the literature and
though validation of clusters from phenotype discovery analysis. These curated
marker lists are available in the pRoloc software.
A SVM classiﬁer, with a radial basis function kernel, using class speciﬁc weights
was used for classiﬁcation of unassigned proteins to one of the 14 known classes.
The weights used in classiﬁcation were set to be inversely proportional to the
subcellular class frequencies to account for class imbalance. Algorithmic
performance of the SVM on the data set was estimated using stratiﬁed ﬁvefold
cross-validation (creating ﬁve test/train partitions), which features an additional
cross-validation on each training partition to optimize free parameters, sigma and
cost, via a grid search (as described in ref. 23). This process was repeated 100 times
and the best cost and sigma parameters were chosen based on the best F1 score; the
harmonic mean of precision and recall. The best sigma was 0.01, which controls the
bandwidth of the Gaussian, and the best cost was 16, which controls the balance
between adherence to the training data and predictive performance on future
unknown examples. As different organelles reﬂect different SVM score
distributions (Supplementary Fig. 16), scoring thresholds were calculated per
subcellular niche and were set based on concordance with gene ontology
annotation to attain a 5% FDR. Unassigned proteins were then classiﬁed to 1 of the
13 compartments according to the SVM prediction if greater than the calculated
class threshold. See also Supplementary Note 1.
Visualization and annotation of spatial proteomics data. To enable straight-
forward access to the data, we have developed the pRolocGUI application
(http://bioconductor.org/packages/devel/bioc/html/pRolocGUI.html), which
provides an interactive visualization interface for spatial proteomics data. It
employs modern JavaScript technology that directly interacts with the R data using
the shiny Web application framework for R (http://shiny.rstudio.com/). The
interface enables users to visualize annotated spatial proteomics data with PCA and
protein proﬁle plots, search for proteins of interest and overlay protein complexes
and functional networks onto the subcellular map. The application can be
used to speciﬁcally explore our mouse pluripotent stem cell data online
(https://lgatto.shinyapps.io/christoforou2015/), or can be installed locally to
visualize data from any spatial proteomics experimental designs with or
without any analysis with the pRoloc pipeline. Documentation and a series of
online tutorial videos for pRolocGUI can be found at http://Computational-
ProteomicsUnit.github.io/pRolocGUI/.
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